# A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation

> **NCT03901092** · PHASE3 · COMPLETED · sponsor: **Avid Radiopharmaceuticals** · enrollment: 242 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** flortaucipir F 18

## Key facts

- **NCT ID:** NCT03901092
- **Lead sponsor:** Avid Radiopharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-26
- **Primary completion:** 2019-04-26
- **Final completion:** 2019-04-26
- **Target enrollment:** 242 (ACTUAL)
- **Last updated:** 2020-09-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03901092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03901092, "A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03901092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*